UPDATED DATA FOR CHART IN NSCLC: A MISSED OPPORTUNITY
- 1 April 2000
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 55 (1) , 85-86
- https://doi.org/10.1016/s0167-8140(00)00174-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999
- An Uncharted CountryClinical Oncology, 1999
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 1997
- Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patientsRadiotherapy and Oncology, 1997
- The Curative Treatment by Radiotherapy Alone of Stage I Non-Small Cell Carcinoma of the LungChest, 1995
- Clinical stage II non-small cell lung cancer treated with radiation therapy alone:The significance of clinically staged ipsilateral hilar adenopathy (N1 disease)Cancer, 1992